Literature DB >> 30733922

Management of Leigh syndrome due to NDUFAF6 variants.

Josef Finsterer1, Fulvio A Scorza2.   

Abstract

Entities:  

Keywords:  Epilepsy; Genotype; Leigh syndrome; Mitochondrial; Phenotype; Stroke-like episode

Year:  2019        PMID: 30733922      PMCID: PMC6358543          DOI: 10.1016/j.ymgmr.2019.100456

Source DB:  PubMed          Journal:  Mol Genet Metab Rep        ISSN: 2214-4269


× No keyword cloud information.
We read with interest the article by Baide-Mairena et al. about three siblings with early-onset Leigh syndrome due to compound heterozygous variants in the NDUFAF6 gene [1]. We have the following comments and concerns. We do not agree with the statement that thiamine is the only compound effective in Leigh-syndrome [1]. In case Leigh syndrome is due to primary coenzyme-Q deficiency, high dose administration of coenzyme-Q can be highly beneficial [2]. Since the basal ganglia lesions were not only hyperintense on T2/FLAIR sequences but also on diffusion-weighted images (DWI) [1], we should be informed whether apparent diffusion coefficient (ADC) maps showed a corresponding hyperintense or hypointense signal. This is of relevance since ADC hyperintensity would suggest the presence of a stroke-like lesion (SLL), which is the morphological equivalent of a stroke-like episode (SLE). SLEs are potentially treatable by application of NO-precursors, particularly l-arginine [3]. It is also of relevance as Leigh syndrome has been reported to manifest in the cerebrum with SLEs [4]. Since SLLs show up as hyperperfusion in the acute phase on PWI, we should be informed if the basal ganglia lesions revealed an increased perfusion at the stage when DWI signals were hyperintense. Since Leigh syndrome may manifest clinically with seizures [5], we should be informed if the individual or family history was positive for seizures or epilepsy in the index cases or their first-degree relatives, and if ever paroxysmal activity was recorded on electroencephalography in any of the three presented patients. Overall, this interesting study could be more meaningful by providing more extensive information about the phenotype of the included siblings, in particular if any of them ever had developed seizures, if the ADC maps were hyper- or hypointense on cerebral MRI, and if the discussion about treatment strategies in patients with Leigh syndrome was revised.

Conflicts of interest

There are no conflicts of interest.

Funding

No funding was received.

Author contribution

JF: design, literature search, discussion, first draft, FAS: critical review, literature search.
  5 in total

1.  Coenzyme Q-responsive Leigh's encephalopathy in two sisters.

Authors:  Lionel Van Maldergem; Frans Trijbels; Salvatore DiMauro; Pavel J Sindelar; Olimpia Musumeci; Antoon Janssen; Xavier Delberghe; Jean-Jacques Martin; Yves Gillerot
Journal:  Ann Neurol       Date:  2002-12       Impact factor: 10.422

2.  8-year retrospective analysis of intravenous arginine therapy for acute metabolic strokes in pediatric mitochondrial disease.

Authors:  Rebecca D Ganetzky; Marni J Falk
Journal:  Mol Genet Metab       Date:  2018-02-02       Impact factor: 4.797

3.  Stroke-like episodes in autosomal recessive cytochrome oxidase deficiency.

Authors:  C Morin; J Dubé; B H Robinson; J Lacroix; J Michaud; M De Braekeleer; G Geoffroy; A Lortie; C Blanchette; M A Lambert; G A Mitchell
Journal:  Ann Neurol       Date:  1999-03       Impact factor: 10.422

Review 4.  Mutations in the mitochondrial complex I assembly factor NDUFAF6 cause isolated bilateral striatal necrosis and progressive dystonia in childhood.

Authors:  Heidy Baide-Mairena; Paula Gaudó; Laura Marti-Sánchez; Sonia Emperador; Angel Sánchez-Montanez; Olga Alonso-Luengo; Marta Correa; Anna Marcè Grau; Juan Darío Ortigoza-Escobar; Rafael Artuch; Elida Vázquez; Mireia Del Toro; Nuria Garrido-Pérez; Eduardo Ruiz-Pesini; Julio Montoya; María Pilar Bayona-Bafaluy; Belén Pérez-Dueñas
Journal:  Mol Genet Metab       Date:  2019-01-05       Impact factor: 4.797

5.  Two new mutations in the MT-TW gene leading to the disruption of the secondary structure of the tRNA(Trp) in patients with Leigh syndrome.

Authors:  Emna Mkaouar-Rebai; Imen Chamkha; Fatma Kammoun; Thouraya Kammoun; Hajer Aloulou; Mongia Hachicha; Chahnez Triki; Faiza Fakhfakh
Journal:  Mol Genet Metab       Date:  2009-03-16       Impact factor: 4.797

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.